Ye Lin
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 9
-
- Cancer, Hypoxia, and Metabolism 4
- Cancer-related molecular mechanisms research 4
- Co-authors
- Haosheng Jin (10 shared papers)Zhixiang Jian (15 shared papers)Min Yu (12 shared papers)Zhixiang Jian (7 shared papers)Baohua Hou (8 shared papers)Guanqun Huang (3 shared papers)Renguo Guan (8 shared papers)Haiyan Liu (1 shared paper)
- Journals
- Cell Death and Disease (3 papers)Frontiers in Oncology (3 papers)Frontiers in Immunology (2 papers)Cancer Medicine (2 papers)International Journal of Surgery (2 papers)
- Partner nations
- ChinaHong KongUnited Kingdom
In The Last Decade
Ye Lin
57 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 86
- Cancer Research 519
- Hepatology 141
- Oncology 288
- Molecular Biology 714
- Pulmonary and Respiratory Medicine 171
Countries citing papers authored by Ye Lin
This map shows the geographic impact of Ye Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Lin more than expected).
Fields of papers citing papers by Ye Lin
This network shows the impact of papers produced by Ye Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Lin. The network helps show where Ye Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ye Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 260 | |
| 2 | 2017 | 132 | |
| 3 | 2009 | 117 | |
| 4 | 2020 | 96 | |
| 5 | 2020 | 79 | |
| 6 | 2019 | 73 | |
| 7 | 2019 | 67 | |
| 8 | 2020 | 61 | |
| 9 | 2015 | 42 | |
| 10 | 2022 | 41 | |
| 11 | 2021 | 34 | |
| 12 | 2018 | 33 | |
| 13 | 2024 | 32 | |
| 14 | 2018 | 30 | |
| 15 | 2020 | 30 | |
| 16 | 2011 | 29 | |
| 17 | 2015 | 28 | |
| 18 | 2024 | 28 | |
| 19 | 2022 | 27 | |
| 20 | 2019 | 25 |
About Ye Lin
Ye Lin is a scholar working on Hepatology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 61 papers that have together received 1.6k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), RNA modifications and cancer (7 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Circular RNAs in diseases (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cancer-related molecular mechanisms research (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). The work is most often cited by research in Cancer Research (519 citations), Hepatology (141 citations), Oncology (288 citations), Molecular Biology (714 citations) and Pulmonary and Respiratory Medicine (171 citations). Ye Lin has collaborated with scholars based in China, Hong Kong and United Kingdom. Frequent co-authors include Haosheng Jin, Zhixiang Jian, Min Yu, Zhixiang Jian, Baohua Hou, Guanqun Huang, Renguo Guan, Haiyan Liu, Chong Wang and Jianhong Huang. Their work appears in journals such as Cell Death and Disease, Frontiers in Oncology, Frontiers in Immunology, Cancer Medicine and International Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.